| Literature DB >> 26770057 |
Nafisa Ali1, Mette S Sørensen2, Torben L Sørensen3, Panteleimon Mortzos1.
Abstract
PURPOSE: Assessing health-related quality of life in patients with strabismus is important in evaluating the clinical benefits of strabismus treatment. The purpose of this study was to translate the Adult Strabismus Quality of Life Questionnaire (AS-20) into Danish and evaluate its reliability and validity in adult patients with strabismus in Denmark.Entities:
Keywords: AS-20; questionnaire; strabismus
Year: 2015 PMID: 26770057 PMCID: PMC4706120 DOI: 10.2147/OPTH.S90844
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Summary of demographic and clinical data of all subjects
| Group | Age (years) | Sex (M/F) | Diagnosis | Diplopia (N) |
|---|---|---|---|---|
| Strabismus | N=64 | 17/40 | N of exotropia =30 | 22 |
| Median =46 | N of esotropia =25 | |||
| Min–max =17–81 | ||||
| Controls | N=13 | 5/8 | ||
| Median =50 | ||||
| Min–max =30–74 |
Abbreviations: M, male; F, female; N, number.
Inter-item correlation matrix
| Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | |
| Q1 | 1.000 | 0.806 | 0.844 | 0.859 | 0.572 | 0.798 | 0.640 | 0.774 | 0.622 | 0.706 |
| Q2 | 0.806 | 1.000 | 0.744 | 0.811 | 0.457 | 0.666 | 0.628 | 0.675 | 0.677 | 0.601 |
| Q3 | 0.844 | 0.744 | 1.000 | 0.861 | 0.463 | 0.784 | 0.568 | 0.744 | 0.574 | 0.666 |
| Q4 | 0.859 | 0.811 | 0.861 | 1.000 | 0.529 | 0.782 | 0.658 | 0.823 | 0.636 | 0.759 |
| Q5 | 0.572 | 0.457 | 0.463 | 0.529 | 1.000 | 0.574 | 0.557 | 0.675 | 0.636 | 0.651 |
| Q6 | 0.798 | 0.666 | 0.784 | 0.782 | 0.574 | 1.000 | 0.625 | 0.785 | 0.592 | 0.717 |
| Q7 | 0.640 | 0.628 | 0.568 | 0.658 | 0.557 | 0.625 | 1.000 | 0.624 | 0.722 | 0.697 |
| Q8 | 0.774 | 0.675 | 0.744 | 0.823 | 0.675 | 0.785 | 0.624 | 1.000 | 0.685 | 0.770 |
| Q9 | 0.622 | 0.677 | 0.574 | 0.636 | 0.636 | 0.592 | 0.722 | 0.685 | 1.000 | 0.527 |
| Q10 | 0.706 | 0.601 | 0.666 | 0.759 | 0.651 | 0.717 | 0.697 | 0.770 | 0.527 | 1.000 |
| Q11 | 1.000 | 0.341 | 0.479 | 0.179 | 0.479 | 0.344 | 0.215 | 0.446 | 0.443 | 0.041 |
| Q12 | 0.341 | 1.000 | 0.527 | 0.272 | 0.581 | 0.271 | 0.235 | 0.325 | 0.658 | 0.195 |
| Q13 | 0.479 | 0.527 | 1.000 | 0.104 | 0.263 | 0.381 | 0.114 | 0.634 | 0.479 | 0.165 |
| Q15 | 0.179 | 0.272 | 0.104 | 1.000 | 0.416 | 0.269 | 0.160 | 0.206 | 0.502 | 0.223 |
| Q16 | 0.479 | 0.581 | 0.263 | 0.416 | 1.000 | 0.191 | 0.264 | 0.295 | 0.682 | 0.198 |
| Q17 | 0.344 | 0.271 | 0.381 | 0.269 | 0.191 | 1.000 | 0.413 | 0.548 | 0.311 | 0.081 |
| Q18 | 0.215 | 0.235 | 0.114 | 0.160 | 0.264 | 0.413 | 1.000 | 0.267 | 0.238 | 0.009 |
| Q19 | 0.446 | 0.325 | 0.634 | 0.206 | 0.295 | 0.548 | 0.267 | 1.000 | 0.459 | 0.111 |
| Q20 | 0.443 | 0.658 | 0.479 | 0.502 | 0.682 | 0.311 | 0.238 | 0.459 | 1.000 | 0.243 |
| Q14 | 0.041 | 0.195 | 0.165 | 0.223 | 0.198 | 0.081 | 0.009 | 0.111 | 0.243 | 1.000 |
Notes: Items 1–10 belong to the psychosocial subscale and items 11–20 belong to the functional subscale. All 20 items had item-internal consistencies >0.5. All but item 14 had item discrimination <0.50. For item details, see Supplementary material.
Ceiling/floor effect in healthy patients and patients with strabismus
| Question number | Ceiling/floor (%)
| Test–retest ( | |
|---|---|---|---|
| Strabismus | Healthy | ||
| Q1 | 14/19 | 92/8 | 0.56 |
| Q2 | 10/19 | 100/0 | 0.18 |
| Q3 | 16/17 | 100/0 | 0.70 |
| Q4 | 12/21 | 100/0 | 0.15 |
| Q5 | 43/9 | 100/0 | 0.15 |
| Q6 | 22/16 | 100/0 | 0.41 |
| Q7 | 26/3 | 100/0 | 0.18 |
| Q8 | 38/16 | 100/0 | 0.15 |
| Q9 | 29/3 | 100/0 | 0.31 |
| Q10 | 40/12 | 100/0 | 1.0 |
| Q11 | 21/5 | 92/8 | 0.10 |
| Q12 | 62/2 | 92/8 | 0.31 |
| Q13 | 45/2 | 85/8 | 0.48 |
| Q14 | 95/16 | 92/8 | 0.51 |
| Q15 | 3/3 | 85/8 | 0.89 |
| Q16 | 26/2 | 77/8 | 1.0 |
| Q17 | 26/2 | 92/8 | 0.25 |
| Q18 | 10/7 | 69/8 | 0.83 |
| Q19 | 40/3 | 92/8 | 0.48 |
| Q20 | 24/9 | 92/8 | 0.25 |
Note: Test–retest was performed in 12 randomly selected patients.
Difference in AS-20 score between patients with diplopia and patients without diplopia
| Nondiplopic median (IQR) | Diplopic median (IQR) | ||
|---|---|---|---|
| Q1 | 62.5 (25–100) | 50.00 (0–75) | 0.78 |
| Q2 | 75.00 (50–100) | 25.00 (25–75) | 0.007 |
| Q3 | 62.5 (25–75) | 25.00 (25–75) | 0.69 |
| Q4 | 50.00 (25–75) | 25.00 (25–75) | 0.192 |
| Q5 | 25.00 (0–75) | 0 (0–25) | 0.241 |
| Q6 | 50.00 (25–75) | 25.00 (0–25) | 0.185 |
| Q7 | 50.00 (25–50) | 0 (0–50) | 0.036 |
| Q8 | 25.00 (25–75) | 0 (0–50) | 0.012 |
| Q9 | 25.00 (0–50) | 0 (0–50) | 0.051 |
| Q10 | 25.00 (0–75) | 25.00 (0–50) | 0.507 |
| Q11 | 50.00 (0–75) | 50.00 (50–75) | 0.136 |
| Q12 | 0 (0–25) | 0 (0–25) | 0.736 |
| Q13 | 25.00 (0–25) | 25.00 (0–50) | 0.462 |
| Q14 | 50.00 (25–50) | 50.00 (25–50) | 0.832 |
| Q15 | 50.00 (50–75) | 50.00 (25–75) | 0.132 |
| Q16 | 25.00 (25–75) | 25.00 (25–75) | 0.857 |
| Q17 | 25.00 (00–50) | 50.00 (25–50) | 0.161 |
| Q18 | 50.00 (25–75) | 50.00 (50–75) | 0.419 |
| Q19 | 25.00 (0–25) | 25.00 (0–50) | 0.705 |
| Q20 | 25.00 (0–50) | 50.00 (0–75) | 0.262 |
Note:
Significant differences between the two groups.
Abbreviations: AS-20, Adult Strabismus Quality of Life Questionnaire; IQR, interquartile range.